Malejczyk J, Majewski S, Jablonska S, Rogozinski T T, Orth G
Department of Histology and Embryology, Warsaw Medical School, Poland.
Int J Cancer. 1989 Feb 15;43(2):209-14. doi: 10.1002/ijc.2910430206.
Natural-cell-mediated cytotoxicity against K-562 erythroleukemic cells and human papillomavirus (HPV)-16 harboring Sk-v keratinocytes was tested in 38 age- and sex-matched healthy volunteers and in patients with HPV-induced benign and malignant anogenital lesions: 9 persons with HPV-16-induced bowenoid papulosis (BP), 8 with anogenital carcinomas (5 with HPV-16- or 33-associated squamous-cell carcinomas of Bowen's type and 3 with HPV-6-associated Buschke-Loewenstein verrucous carcinomas) and 12 with HPV-6-induced condylomata acuminata. Both K-562 and Sk-v cells were killed by a non-adherent CD16+ subset of PBMC as revealed by cell fractionation on the basis of their adherence to plastic and by treatment with Leu-IIb monoclonal antibody (MAb) and complement. "Cold" target competitive assays demonstrated that both cell types inhibited lysis of labelled Sk-v cells. In patients with BP and anogenital carcinomas induced by HPV-16 or 33, there was a significant (at least at p less than 0.01) decrease of Sk-v cell lysis as compared with the healthy control group. Anti-K-562 activity was not affected. In patients with anogenital carcinomas the degree of Sk-v lysis was decreased in proportion to the duration of lesions (correlation coefficient-r = -0.79). Neither anti-K-562 nor anti-Sk-v cytotoxicities were significantly affected in patients with condylomata and with HPV-6 associated verrucous carcinomas. Short-term (3 hr) pre-incubation of normal PBMC with sera from patients with BP and HPV-16-associated anogenital carcinomas resulted in significant inhibition of their ability to lyse Sk-v cells. Lysis of K-562 cells remained unaffected. In patients with carcinomas, the suppressive effect of sera was associated with a lowering of the ability of their PBMC to lyse Sk-v cells (r = -0.79). In patients with longer tumor persistence, the suppressive effect of serum was proportionally higher (r = 0.86).
在38名年龄和性别匹配的健康志愿者以及患有HPV诱导的良性和恶性肛门生殖器病变的患者中,测试了对K-562红白血病细胞和携带HPV-16的Sk-v角质形成细胞的自然细胞介导的细胞毒性:9例HPV-16诱导的鲍温样丘疹病(BP)患者、8例肛门生殖器癌患者(5例HPV-16或33相关的鲍温型鳞状细胞癌和3例HPV-6相关的Buschke-Loewenstein疣状癌)以及12例HPV-6诱导的尖锐湿疣患者。如通过基于对塑料的粘附性进行细胞分级分离以及用Leu-IIb单克隆抗体(MAb)和补体处理所揭示的,K-562和Sk-v细胞均被PBMC的非粘附性CD16 +亚群杀死。“冷”靶标竞争试验表明,两种细胞类型均抑制标记的Sk-v细胞的裂解。在由HPV-16或33诱导的BP和肛门生殖器癌患者中,与健康对照组相比,Sk-v细胞裂解有显著(至少p小于0.01)降低。抗K-562活性未受影响。在肛门生殖器癌患者中,Sk-v裂解程度与病变持续时间成比例降低(相关系数r = -0.79)。在尖锐湿疣患者和HPV-6相关疣状癌患者中,抗K-562和抗Sk-v细胞毒性均未受到显著影响。用BP患者和HPV-16相关肛门生殖器癌患者的血清对正常PBMC进行短期(3小时)预孵育,导致其裂解Sk-v细胞的能力受到显著抑制。K-562细胞的裂解未受影响。在癌症患者中,血清的抑制作用与其PBMC裂解Sk-v细胞的能力降低有关(r = -0.79)。在肿瘤持续时间较长的患者中,血清的抑制作用成比例更高(r = 0.86)。